Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06810154

Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants

Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants: a Stepped-Wedge Cluster Randomized Trial

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
2,170 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
0 Hours – 72 Hours
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate whether multi-strain probiotics of lactobacillus and bifidobacterium can prevent necrotizing enterocolitis (NEC) in preterm infants born at less than 32 weeks of gestation. The main questions it aims to answer are: * Does the use of a multi-strain probiotic combination reduce the incidence of NEC in preterm infants? * Are there any adverse effects associated with the administration of this probiotic combination?

Detailed description

Researchers will compare outcomes between two phases: Control Phase: No probiotics will be administered, and outcomes will be recorded to establish baseline NEC rates. Intervention Phase: Participants will receive a daily multi-strain probiotic combination (0.5 g sachet) starting within 24 hours of enteral feeding initiation. Participants will be: * Preterm infants born at \<32 weeks' gestation and \<1500 g birth weight. The study uses a stepped-wedge cluster randomized trial (SW-CRT) design, where neonatal intensive care units (NICUs) transition from the control phase to the intervention phase at pre-specified intervals. Individual consent will be obtained for probiotic administration and data collection during the intervention phase, and data collection-only consent will be sought during the control phase. This trial is designed to provide high-quality evidence on the efficacy and safety of probiotics in preventing NEC in preterm infants.

Conditions

Interventions

TypeNameDescription
BIOLOGICALMulti-strain probioticsInfants will be started on probiotics (Bifidobacterium and Lacticaseibacillus) with enetral feed.

Timeline

Start date
2025-06-01
Primary completion
2027-05-30
Completion
2028-05-30
First posted
2025-02-05
Last updated
2025-02-05

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06810154. Inclusion in this directory is not an endorsement.